0001127602-21-007295.txt : 20210223 0001127602-21-007295.hdr.sgml : 20210223 20210223162502 ACCESSION NUMBER: 0001127602-21-007295 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210219 FILED AS OF DATE: 20210223 DATE AS OF CHANGE: 20210223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Babu Yarlagadda S CENTRAL INDEX KEY: 0001452635 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 21665850 MAIL ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-02-19 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001452635 Babu Yarlagadda S 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703 1 Senior VP - Drug Discovery Common Stock 2021-02-19 4 M 0 50000 4.15 A 205587 D Common Stock 2021-02-19 4 F 0 22431 11.53 D 183156 D Stock Option (Right to Buy) 4.15 2021-02-19 4 M 0 50000 0 D 2012-03-01 2021-03-01 Common Stock 50000 0 D Shares of Common Stock delivered to the Company to satisfy payment of exercise price and tax withholding in connection with stock option exercise. /s/ Alane P. Barnes, by power of attorney 2021-02-23